We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleA phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer.AuthorsTolcher, A. W.; Quinn, D. I.; Ferrari, A.; Ahmann, F.; Giaccone, G.; Drake, T.; Keating, A.; de Bono, J. S.PublicationAnnals of Oncology, 2012, Vol 23, Issue 4, p968ISSN0923-7534Publication typearticleDOI10.1093/annonc/mdr353